Results 171 to 180 of about 10,208 (189)

Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection [PDF]

Mucosal Immunology, 2019
T cell-mediated protection against Mycobacterium tuberculosis (Mtb) is dependent upon the ability to localize within the site of pulmonary infection and directly interact with infected cells. In turn, vaccine strategies to improve rapid T cell targeting of Mtb-infected cells after pulmonary exposure are being actively pursued.
Joshua S Woodworth, Dennis Christensen, Joseph P Cassidy   +2 more
exaly   +5 more sources

H56 Comparison of the efficacy and safety of candesartan cilexetil 4, 8 and 12 mg with placebo and enalapril 10 mg in patients with mild to moderate essential hypertension [PDF]

American Journal of Hypertension, 1997
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Comparison ofβ-Adrenergic blocking activity of DCI, H56/28, ICI50172, LB46, methoxamine, MJ 1999 and propranolol in the blood perfused canine papillary muscle preparation

Experientia, 1970
Nachweis, dass derβ-Blocker LB46 am blutperfundierten Papillarmuskel des Hundes eine grossere Aktivitat aufweist als 6 andere bekannteβ-Blocker.
K, Hashimoto, M, Endoh, K, Tamura, N, Taira   +3 more
openaire   +2 more sources

Structure of the O-polysaccharide of Yersinia frederiksenii H56-36/81 (serotype O:60) containing 4-deoxy-d-arabino-hexose

Russian Chemical Bulletin, 2016
Aiming at creation of the chemical basis for serotyping of strains of Yersinia spp., we studied the O-specific polysaccharide (OPS) of Yersinia frederiksenii H56-36/81 belonging to serotype O:60. A branched polysaccharide was obtained by mild alkaline degradation of the lipopolysaccharide (LPS) isolated from bacterial cells by the phenol—water ...
O. V. Sizova, A. S. Shashkov, R. Z. Shaikhutdinova, S. A. Ivanov, S. V. Dentovskaya, Yu. A. Knirel   +5 more
openaire   +1 more source

TWO NEW ESCHERICHIA COLI O ANTIGENS, O162 AND O163, AND ONE NEW H ANTIGEN, H56. WITHDRAWAL OF H ANTIGEN H50

Acta Pathologica Microbiologica Scandinavica Section B Microbiology, 1975
Three E. coli strains representing strains from faeces of normal persons were established as antigenic test strains of two new O antigens, O162 and O163, and one new H antigen, H56.
I, ørskov, F, ørskov, K A, Bettelheim, M E, Chandler   +3 more
exaly   +3 more sources

MPEC 2024-H56 : 2024 HZ

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

MPEC 2025-H56 : 2016 CP433

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Lancet Infectious Diseases, The
People with tuberculosis who complete treatment remain at risk of recurrent disease. The vaccine H56:IC31 has been shown to be safe and immunogenic in phase 1 and 2 studies, but whether it can reduce the risk of tuberculosis recurrence is unknown.In a double-blind, randomised, placebo-controlled, phase 2b trial in South Africa (five clinical trial ...
Dereck Tait, Elisa Nemes, Morten Ruhwald
exaly   +3 more sources

Comparison of Β-Adrenergic blocking activity of dichloroisoprenaline (H 56/28, I.C.I. 50172, LB46), methoxamine (MJ 1999) and propranolol in the canine femoral vascular bed

Experientia, 1969
Die blockierende Wirkung intra- arteriell verabreichter,Β-adrenergischer Mittel wurde am femoralen Gefassgebiet des Hundes untersucht. DCI, H 56/28 und LB 46 per se regten den arteriellen Blutstrom mit zunehmender Dosierung an, wahrend Methoxamin in umgekehrter Weise wirkte. Eine hemmende Wirkung auf den durch Isoprenalin angeregten Blutstrom fand sich
K, Hashimoto, S, Matsumura, N, Sano, N, Taira   +3 more
openaire   +2 more sources

Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial

The Journal of Infectious Diseases
Abstract Background H56:IC31 is a candidate vaccine against tuberculosis (TB) with the potential to reduce TB recurrence rate. It is thus important for future clinical trials to demonstrate safety and immunogenicity of H56:IC31 in individuals treated for TB.
Dereck Tait, Andreas Diacon, Álvaro H Borges, Elana van Brakel, David Hokey, Kathryn T Rutkowski, Devin J Hunt, Marisa Russell, Peter L Andersen, Ingrid Kromann, Morten Ruhwald, Gavin Churchyard, Rodney Dawson   +12 more
openaire   +3 more sources